David P Marriott

Title: David P Marriott: Innovator in Pharmaceutical Formulations

Introduction

David P Marriott is a notable inventor based in Radcliffe-on-Trent, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of angiotensin converting enzyme inhibitors. His work has implications for various medical applications, showcasing his expertise and dedication to innovation.

Latest Patents

David P Marriott holds a patent for "Angiotensin converting enzyme inhibitors and their formulation and use." This patent describes compounds of formula I, which are essential in the formulation of effective medications. His innovative approach has led to advancements in the treatment of conditions related to the renin-angiotensin system.

Career Highlights

Throughout his career, David has been associated with Fisons Ltd., a company known for its commitment to pharmaceutical research and development. His role at Fisons Ltd. has allowed him to focus on creating impactful solutions in the healthcare sector. With 1 patent to his name, he has established himself as a valuable contributor to the industry.

Collaborations

David has collaborated with esteemed colleagues, including Colin Bennion and Anthony R Cook. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas. Together, they have worked on projects that enhance the efficacy of pharmaceutical formulations.

Conclusion

David P Marriott's contributions to the field of pharmaceuticals, particularly through his patent on angiotensin converting enzyme inhibitors, highlight his role as an innovator. His work continues to influence the development of effective medical treatments, showcasing the importance of research and collaboration in advancing healthcare solutions.